Cargando…

Complexities of Adherence and Post-Cancer Lymphedema Management

Breast cancer survivors are at increased risk for breast cancer-related lymphedema (BCRL), a chronic, debilitating, condition that is progressive and requires lifelong self-management. Up to 40% of 3 million breast cancer survivors in the US will develop BCRL, which has no cure, is irreversible, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostby, Pamela L., Armer, Jane M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695861/
https://www.ncbi.nlm.nih.gov/pubmed/26580657
http://dx.doi.org/10.3390/jpm5040370
_version_ 1782407707373862912
author Ostby, Pamela L.
Armer, Jane M.
author_facet Ostby, Pamela L.
Armer, Jane M.
author_sort Ostby, Pamela L.
collection PubMed
description Breast cancer survivors are at increased risk for breast cancer-related lymphedema (BCRL), a chronic, debilitating, condition that is progressive and requires lifelong self-management. Up to 40% of 3 million breast cancer survivors in the US will develop BCRL, which has no cure, is irreversible, and requires self-management with regimens that may include multiple components. The complexities of treatment can negatively affect adherence to BCRL self-management which is critical to preventing progressive swelling and infection. The aim of this review of contemporary literature published from 2005–2015 is to examine the complexities of BCRL self-management, to identify adherence-focused studies relevant to BCRL, and to summarize barriers to self-management of BCRL. Six electronic indices were searched from which 120 articles were retrieved; 17 were BCRL-focused; and eight met inclusion criteria. Seventeen of 120 articles identified barriers to self-management of BCRL such as complexities of treatment regimens, symptom burden, balance of time for treatment and life demands, and lack of education and support; however, only eight studies included outcome measures of adherence to BCRL treatment regimens with a subsequent improvement in reduced limb volumes and/or perceptions of self-efficacy and self-regulation. A major limitation is the few number of rigorously developed outcome measures of BCRL adherence. In addition, randomized studies are needed with larger sample sizes to establish adequate levels of evidence for establishing best practice standards for improving adherence to BCRL self-management treatment regimens.
format Online
Article
Text
id pubmed-4695861
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-46958612016-01-19 Complexities of Adherence and Post-Cancer Lymphedema Management Ostby, Pamela L. Armer, Jane M. J Pers Med Article Breast cancer survivors are at increased risk for breast cancer-related lymphedema (BCRL), a chronic, debilitating, condition that is progressive and requires lifelong self-management. Up to 40% of 3 million breast cancer survivors in the US will develop BCRL, which has no cure, is irreversible, and requires self-management with regimens that may include multiple components. The complexities of treatment can negatively affect adherence to BCRL self-management which is critical to preventing progressive swelling and infection. The aim of this review of contemporary literature published from 2005–2015 is to examine the complexities of BCRL self-management, to identify adherence-focused studies relevant to BCRL, and to summarize barriers to self-management of BCRL. Six electronic indices were searched from which 120 articles were retrieved; 17 were BCRL-focused; and eight met inclusion criteria. Seventeen of 120 articles identified barriers to self-management of BCRL such as complexities of treatment regimens, symptom burden, balance of time for treatment and life demands, and lack of education and support; however, only eight studies included outcome measures of adherence to BCRL treatment regimens with a subsequent improvement in reduced limb volumes and/or perceptions of self-efficacy and self-regulation. A major limitation is the few number of rigorously developed outcome measures of BCRL adherence. In addition, randomized studies are needed with larger sample sizes to establish adequate levels of evidence for establishing best practice standards for improving adherence to BCRL self-management treatment regimens. MDPI 2015-11-16 /pmc/articles/PMC4695861/ /pubmed/26580657 http://dx.doi.org/10.3390/jpm5040370 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ostby, Pamela L.
Armer, Jane M.
Complexities of Adherence and Post-Cancer Lymphedema Management
title Complexities of Adherence and Post-Cancer Lymphedema Management
title_full Complexities of Adherence and Post-Cancer Lymphedema Management
title_fullStr Complexities of Adherence and Post-Cancer Lymphedema Management
title_full_unstemmed Complexities of Adherence and Post-Cancer Lymphedema Management
title_short Complexities of Adherence and Post-Cancer Lymphedema Management
title_sort complexities of adherence and post-cancer lymphedema management
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695861/
https://www.ncbi.nlm.nih.gov/pubmed/26580657
http://dx.doi.org/10.3390/jpm5040370
work_keys_str_mv AT ostbypamelal complexitiesofadherenceandpostcancerlymphedemamanagement
AT armerjanem complexitiesofadherenceandpostcancerlymphedemamanagement